Clinical Trial Update: Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing hypofractionated versus conventional chemoradiotherapy after induction chemo-immunotherapy for unresectable esophageal squamous…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Esophageal Squamous Cell Carcinoma (ESCC) | Phase 2 | Status: RECRUITING